NCT03920800View on ClinicalTrials.gov

Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

November 20, 2019

Study Completion Date

November 20, 2019

Conditions
High-Grade Squamous Intraepithelial Lesions
Interventions
OTHER

Data extraction from medical files

Data extraction from medical files

BIOLOGICAL

Immunohistochemistry

Immunohistochemistry with Ki67 and p16 antibodies on residual samples, if this had not been foreseen in the standard of care management of the patient.

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Catherine Vanpachterbeke

OTHER

NCT03920800 - Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions | Biotech Hunter | Biotech Hunter